Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Common Stock | Options Exercise | $228K | +4.5K | +450000% | $50.61 | 4.5K | Dec 9, 2022 | Direct | |
transaction | CNMD | Common Stock | Sale | -$402K | -4.5K | -99.98% | $89.31 | 1 | Dec 9, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -4.5K | -11.36% | $0.00 | 35.1K | Dec 9, 2022 | Common Stock | 4.5K | $50.61 | Direct | F2 |
Id | Content |
---|---|
F1 | The sale reported was effected pursuant to a previously adopted Rule 10b5-1 Trading Plan. |
F2 | Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. |